The University of Chicago is committed to supporting the rapid development of new technologies and life-saving therapeutics in the battle against the coronavirus (COVID-19) pandemic.
A non-exclusive, royalty-free license will be made available, as applicable, along with the licensees’ commitment to support the development and distribution of innovations to prevent, diagnose, treat and contain COVID-19 during the pandemic. This time-limited license is offered for any COVID-19-related inventions where legally possible. Learn more…
